Poison gas tested as lifesaver for critically ill patients
NCT ID NCT04870125
Summary
This early-stage study is testing whether carefully controlled, low doses of inhaled carbon monoxide can be safely given to patients with severe lung failure caused by infections like sepsis or pneumonia. Researchers want to see if a personalized dosing method can reliably reach a target level in the blood without causing harm. They will also check for early signs that the treatment might help reduce lung inflammation and organ damage in these critically ill patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Duke University Hospital
Durham, North Carolina, 27710, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
New York-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York, 11215, United States
-
Washington University
St Louis, Missouri, 63110, United States
-
Weill Cornell Medical College
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.